ArticleJournal of thoracic disease2025
Comparative efficacy and safety of PD-1/PD-L1 inhibitors versus docetaxel in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
Siyu Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.